Business
The economics of coffee: A visual breakdown

The economics of coffee: A visual breakdown

Caffeine dreams

Giuseppe Lavazza, chairman of one of the world's leading coffee roasters, expects customers to be able to get their caffeine fix cheaper in the coming months, as consumers begin to benefit from the falling price of wholesale beans. With more than 60% of Americans drinking coffee every single day, you might expect the price of coffee to be headline news.

But, even if coffee wholesale prices do tumble, your morning fix — particularly if bought from a cafe — is unlikely to change much.

A study in the UK from 2019, reveals the breakdown of the costs of a typical cup of coffee, finding that just ~4% of a your morning cup is actually for the coffee itself — which worked out to about £0.10 ($0.13). The figures would undoubtedly be higher today — a £2.50 ($3.20) cup of coffee in the UK is a rare sight these days — but the proportions would be similar. Indeed, if you have a particularly fancy drink order, with lots of sweeteners or alternative milks, then the actual beans will be an even smaller share of the costs.

That means, even if the wholesale cost of coffee were to plunge by 40-50%, the cost savings likely to be passed on to consumers would be unlikely to be more than a few cents, as the price of your daily caffeine fix is much more dependent on shop rent and staff wages.

A bitter brew

Although a few years out of date, and from just one study in the UK, the breakdown gives a good sense of just how complicated the coffee supply chain is. The coffee roaster usually accounts for most of the cost of the actual coffee, while exporters, transporters and processors take their cuts, leaving the actual grower with around just 10% of the coffee revenue. In this study, that worked to be just one penny from a typical £2.50 ($3.20) cup of coffee.

More Business

See all Business
business

Monster surges on energy drink buzz, while Celsius sinks on distribution concerns

Shares of Monster Beverage climbed 5% after the bell on Thursday, and held most of those gains into early trading on Friday, following strong Q3 results.

The energy drink giant topped market expectations, with quarterly sales up 17% year-over-year to $2.2 billion and adjusted net profits growing 41% to $524.5 million — 11% ahead of Wall Street’s estimates. In the report, Monster highlighted its zero-sugar line and new product launches, with a stack of novel flavors already released this year, as bright spots.

During a call with analysts, Chief Executive Hilton Schlosberg said that the global energy drink category “remains healthy with robust growth,” the WSJ reported, adding that demand for more affordable caffeinated drinks is rising as coffee has become “really expensive.”

Meanwhile, rival beverage business Celsius saw shares fall as much as 23% on its Q3 results yesterday — despite beating expectations, with revenue jumping 173% — largely due to concerns about a change in the company’s distribution channel, as its newly acquired Alani Nu brand joins the PepsiCo distribution network.

President Trump Announces Negotiated Lower Prices For GLP-1 Weight Loss Drugs

White House unveils deal with Novo, Lilly on weight-loss drugs

The latest deal the administration has reached with Big Pharma is perhaps the one that would impact the highest number of Americans.

Mounjaro injections

Blockbuster drug sales power Big Pharma’s Q3 earnings as tariff fears fade

Meanwhile, Novo Nordisk and Pfizer are in an escalating bid-off for obesity biotech Metsera.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.